Tendon pain adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From July 2006 to June 2026, FDA received 7,477 adverse event reports that record the MedDRA preferred term Tendon pain. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 360 reports in the 12 months to June 2026 and 332 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,155 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 360 (under 0.1%) record this term. Reports for patients aged 45 to 64 were 33.2% of the reports that record this term and 20% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 150 drug pages with 5 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Tendon pain name as a suspect product, in order of name
Drug	Class	Reports with this term
Abatacept	Selective T cell costimulation modulator	5
Acetylsalicylic Acid		8
Aclasta		5
Actemra	Interleukin-6 receptor antagonist	26
Adalimumab	Tumor necrosis factor blocker	11
Allopurinol	Xanthine oxidase inhibitor	9
Amitriptyline		6
Amlodipine	Calcium channel blocker	20
Amoxicillin	Penicillin-class antibacterial	8
Amoxicillin Clavulanate Potassium		9
Anastrozole	Aromatase inhibitor	15
Arimidex	Aromatase inhibitor	7
Atorvastatin		92
Atorvastatin calcium	HMG-CoA reductase inhibitor	19
Avelox		219
Azithromycin	Macrolide antimicrobial	7
Bempedoic acid	Adenosine Triphosphate-Citrate lyase inhibitor	11
Cefazolin	Cephalosporin antibacterial	7
Cefpodoxime		5
Cefuroxime	Cephalosporin antibacterial	9
Cefuroxime axetil	Cephalosporin antibacterial	6
Celebrex	Nonsteroidal anti-inflammatory drug	16
Celecoxib	Nonsteroidal anti-inflammatory drug	14
Cimzia	Tumor necrosis factor blocker	28
Cipro	Corticosteroid	308
Ciprobay		19
Ciprofloxacin	Fluoroquinolone antibacterial	1,649
Ciprofloxacin hcl	Fluoroquinolone antibacterial	87
Ciprofloxacin hydrochloride	Fluoroquinolone antibacterial	113
Ciprofloxacin Monohydrochloride		11
Ciproxin		15
Clarithromycin	Macrolide antimicrobial	8
Clindamycin	Lincosamide antibacterial	22
Clopidogrel	P2Y12 platelet inhibitor	12
Cosentyx	Interleukin-17A antagonist	128
Crestor	HMG-CoA reductase inhibitor	36
Cyclophosphamide	Alkylating drug	9
Cymbalta		16
Darunavir	Protease inhibitor	6
Desoximetasone	Corticosteroid	8
Dexamethasone	Corticosteroid	6
Diclofenac	Nonsteroidal anti-inflammatory drug	20
Diltiazem		25
Diltiazem hydrochloride	Calcium channel blocker	8
Dolutegravir		6
Doxycycline	Tetracycline-class drug	31
Dupixent	Interleukin-4 receptor alpha antagonist	53
Eligard	Gonadotropin releasing hormone receptor agonist	6
Eliquis	Factor Xa inhibitor	7
Enbrel	Tumor necrosis factor blocker	174
Entyvio	Integrin receptor antagonist	5
Euthyrox		5
Eviplera		6
Exemestane	Aromatase inhibitor	5
Ezetimibe	Dietary cholesterol absorption inhibitor	5
Ezetrol		8
Filgrastim	Leukocyte growth factor	9
Flagyl	Nitroimidazole antimicrobial	10
Flomax		6
Foradil		6
Forteo	Parathyroid hormone analog	17
Foster		6
Fulvestrant	Estrogen receptor antagonist	11
Gabapentin	Anti-epileptic agent	15
Humira		215
Humira 40 Mg/0 8 Ml Pen		6
Hydrocortisone	Corticosteroid	17
Hydromorphone hydrochloride	Opioid agonist	5
Ibuprofen	Nonsteroidal anti-inflammatory drug	20
Imbruvica	Kinase inhibitor	14
Inflectra	Tumor necrosis factor blocker	8
Infliximab	Tumor necrosis factor blocker	16
Kevzara	Interleukin-6 receptor antagonist	6
Kisqali	Kinase inhibitor	10
Leflunomide	Antirheumatic agent	8
Leqvio		7
Letrozole	Aromatase inhibitor	24
Levaquin		718
Levofloxacin	Fluoroquinolone antibacterial	1,133
Levofloxacin 500 Mg		20
Linezolid	Oxazolidinone antibacterial	8
Lipitor	HMG-CoA reductase inhibitor	25
Losartan	Angiotensin 2 receptor blocker	8
Lyrica		21
Meloxicam	Nonsteroidal anti-inflammatory drug	7
Methotrexate	Folate analog metabolic inhibitor	79
Methotrexate sodium	Folate analog metabolic inhibitor	15
Methylprednisolone	Corticosteroid	17
Misoprostol	Prostaglandin E1 analog	6
Morphine Hydrochloride		9
Morphine sulfate	Opioid agonist	8
Moxifloxacin	Fluoroquinolone antibacterial	66
Naproxen	Nonsteroidal anti-inflammatory drug	23
Naproxen sodium	Nonsteroidal anti-inflammatory drug	5
Nexium	Proton pump inhibitor	5
Nexletol	Adenosine Triphosphate-Citrate lyase inhibitor	9
Nexlizet	Adenosine Triphosphate-Citrate lyase inhibitor	11
Nitrofurantoin	Nitrofuran antibacterial	12
Norfloxacin		7
Novothyrox		29
Ofloxacin	Quinolone antimicrobial	99
Ofloxacine		5
Olanzapine	Atypical antipsychotic	6
Omalizumab	Anti-IgE	14
Orencia	Selective T cell costimulation modulator	8
Otezla	Phosphodiesterase 4 inhibitor	28
Pembrolizumab	Programmed death Receptor-1 blocking antibody	6
Piperacillin and tazobactam	Penicillin-class antibacterial	7
Plaquenil	Antimalarial	5
Praluent	PCSK9 inhibitor	17
Prednisolon		10
Prednisolone	Corticosteroid	30
Prednisone	Corticosteroid	63
Pregabalin		36
Prolia	RANK ligand inhibitor	33
Ramipril	Angiotensin converting enzyme inhibitor	12
Remicade	Tumor necrosis factor blocker	17
Repatha	PCSK9 inhibitor	43
Revlimid	Thalidomide analog	8
Rifaximin	Rifamycin antibacterial	9
Rinvoq	Janus kinase inhibitor	19
Ritonavir	Cytochrome P450 3A inhibitor	5
Rituxan	CD20-directed cytolytic antibody	11
Rituximab	CD20-directed cytolytic antibody	28
Rosuvastatin	HMG-CoA reductase inhibitor	35
Rosuvastatin calcium	HMG-CoA reductase inhibitor	8
Simponi	Tumor necrosis factor blocker	21
Simvastatin	HMG-CoA reductase inhibitor	71
Skyrizi	Interleukin-23 antagonist	15
Strensiq		7
Sulfamethoxazole, trimethoprim	Dihydrofolate reductase inhibitor antibacterial	10
Synthroid	l-Thyroxine	10
Tamoxifen citrate	Estrogen Agonist/Antagonist	7
Tamsulosin		9
Tavanic		40
Tocilizumab	Interleukin-6 receptor antagonist	11
Tramadol		8
Tramadol hydrochloride	Opioid agonist	12
Truvada	Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	10
Tymlos		5
Tysabri	Integrin receptor antagonist	5
Venlafaxine	Serotonin and norepinephrine reuptake inhibitor	7
Venlafaxine hydrochloride	Serotonin and norepinephrine reuptake inhibitor	5
Votrient	Kinase inhibitor	5
Xeljanz	Janus kinase inhibitor	43
Xolair	Anti-IgE	17
Xyrem	Central nervous system depressant	5
Zoledronic acid	Bisphosphonate	13
Zometa		6
Zopiclone		11

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 46 pharmacologic classes with 10 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Tendon pain name, in order of name
Class	Reports with this term
Adenosine Triphosphate-Citrate lyase inhibitor	31
Angiotensin 2 receptor blocker	15
Angiotensin converting enzyme inhibitor	15
Anti-epileptic agent	17
Anti-IgE	31
Antirheumatic agent	11
Aromatase inhibitor	51
Bisphosphonate	23
Calcium channel blocker	28
CD20-directed cytolytic antibody	53
Cephalosporin antibacterial	22
Corticosteroid	470
Dihydrofolate reductase inhibitor antibacterial	18
Estrogen Agonist/Antagonist	10
Estrogen receptor antagonist	13
Factor Xa inhibitor	15
Fluoroquinolone antibacterial	3,052
Folate analog metabolic inhibitor	96
HMG-CoA reductase inhibitor	194
Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	10
Integrin receptor antagonist	13
Interleukin-17A antagonist	132
Interleukin-23 antagonist	18
Interleukin-4 receptor alpha antagonist	56
Interleukin-6 receptor antagonist	43
Janus kinase inhibitor	67
Kinase inhibitor	41
l-Thyroxine	10
Lincosamide antibacterial	24
Macrolide antimicrobial	15
Nitrofuran antibacterial	12
Nitroimidazole antimicrobial	10
Nonsteroidal anti-inflammatory drug	113
Opioid agonist	31
P2Y12 platelet inhibitor	17
Parathyroid hormone analog	17
PCSK9 inhibitor	60
Penicillin-class antibacterial	17
Phosphodiesterase 4 inhibitor	28
Proton pump inhibitor	10
Quinolone antimicrobial	99
RANK ligand inhibitor	35
Selective T cell costimulation modulator	13
Serotonin and norepinephrine reuptake inhibitor	14
Tetracycline-class drug	33
Tumor necrosis factor blocker	281

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Tendon pain, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Tendon pain
Age	Reports	Share
Under 2	3	under 0.1%
2 to 11	14	0.2%
12 to 17	26	0.3%
18 to 44	1,837	24.6%
45 to 64	2,481	33.2%
65 to 74	876	11.7%
75 and over	515	6.9%
Age not given	1,725	23.1%

Sex of the patient in the reports that record Tendon pain
Sex	Reports	Share
Female	3,891	52%
Male	3,063	41%
Unknown or not given	523	7%

Age and sex are as the report gives them. 53.1% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Tendon pain: adverse event reports that record this term. https://reportedreactions.com/reaction/tendon-pain/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Tendon pain mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page